Health TrialsbyHealthPanel

Zinc Oxide VS MEBO

ConditionsPressure InjuryPressure Injury Stage 2BedsorePressure Ulcers Stage IIPressure Ulcer, Buttock
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorKing Abdullah Medical City

About this trial

randomize control trial to evaluate the efficacy of using zinc oxide versus moist exposed wound ointment in treatment of second stage pressure ulcer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Willing to participate.

KAMC cases in medical ward, neuroscience ward, and intensive care unit.

Newly cases diagnosed with second stage pressure ulcer according to the European pressure ulcer advisory panel/national pressure ulcer advisory panel (NPUAP) guidelines.

Disqualifiers

Not consenting to participate

Patients with suspected hypersensitivity reactions to any of the topical formulation's ingredients.

Either a category III or IV pressure ulcer.

Evidence of deep tissue injury (exudative drainage, purple or maroon localized area of discolored intact skin or blood-filled blister due to pressure damage).

Trial design

Design model

Parallel

Treatments tested in this trial

  • MEBO Wound Ointment

    Drug

    both are used for second pressure ulcer

  • zinc oxide

    Drug

    both are used to treat second degree pressure ulcer but with no superiority

Treatment groups

76 Participants
are divided into 2 treatment groups
Group A: The zinc oxide groupActive comparator 1 intervention
Group B: MEBO groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Wound healing

Wound healing will be assessed by using Bates-Jensen Wound Assessment Tool (BWAT) daily for both treatments. (BWAT) consists of 13 items to evaluate wound size, type and depth, Each item is graded on a scale of 1 to 5, where a score of 1 indicates progress toward healing while a score of 5 indicates the absence of healing or wound deterioration. Cumulative BWAT scores vary from 13 to 65

Time frame
30 days

Secondary outcomes

1

Recovery time

The duration of treatment will be record at the assessment sheet so Recovery time will be determined from this sheet.

Time frame
30 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

King Abdullah Medical City

Lead sponsor

Source ClinicalTrials.gov
Apply now